Table 3. Multivariate analysis of risk factors for nephrotoxicity.
Characteristic | OR | 95% CI | P-value |
---|---|---|---|
CCr < 88.8 mL/min | 0.41 | 0.29–0.60 | P < 0.01* |
Duration of therapy ≥ 10 days | 2.32 | 1.60–3.36 | P < 0.01* |
Concomitant medications | |||
Furosemide | 2.54 | 1.75–3.68 | P < 0.01* |
Amphotericin B | 3.43 | 1.29–9.11 | P = 0.01* |
Piperacillin–Tazobactam | 3.36 | 2.22–5.06 | P < 0.01* |
Vasopressor drugs | 2.78 | 1.75–4.41 | P < 0.01* |
Average VCM trough concentration ≥ 13 mg/L | 3.60 | 2.49–5.20 | P < 0.01* |
Creatinine clearance: CCr, Vancomycin: VCM, Odds ratio: OR, 95% Confidence interval: 95% CI
*P-values ≤ 0.05 were considered statistically significant.